SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-051654
Filing Date
2021-08-16
Accepted
2021-08-16 17:52:53
Documents
2
Period of Report
2021-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1569
2 POA DOCUMENT poa.txt EX-24.3_1004079 2480
  Complete submission text file 0001209191-21-051654.txt   5428
Mailing Address 2525 28TH STREET, SUITE 100 BOULDER CO 80301
Business Address
Hoerter Steven L. (Reporting) CIK: 0001533451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39269 | Film No.: 211180201

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations